GlassScriptPhysician profile
Avani P Ingley
NPI 1134305030
$3,079.05
in general payments reported to CMS, 2019-2025
24 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $209 · 2021: $192 · 2022: $407 · 2023: $381 · 2024: $325 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.10 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $594.42 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $510.63 | 2022-2025 | Nucala |
| Optinose US, INC. | $459.35 | 2019-2025 | |
| Genzyme Corporation | $281.05 | 2021-2024 | |
| Kaleo, INC. | $201.25 | 2019-2022 | |
| Integra Lifesciences Corporation | $185.20 | 2023-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Medtronic USA, INC. | $177.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $111.29 | 2025 | Tezspire |
| Medtronic, INC. | $99.24 | 2021-2025 | Propel, Stealthstation S8 Platform |
| Alk-Abello, INC | $97.58 | 2019-2023 | Ragwitek, Odactra, Grastek |
| Stryker Corporation | $63.56 | 2019-2022 | |
| Inspire Medical Systems, INC. | $48.70 | 2023-2025 | Inspire |
| Amgen INC. | $48.60 | 2025 | Tezspire |
| Acclarent, INC | $26.30 | 2023 | Acclarent Balloon Inflation Device |
| Boston Scientific Corporation | $26.07 | 2025 | General - Pain Management |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $24.27 | 2025 | Xhance |
| Ars Pharmaceuticals Operations, INC. | $23.24 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $18.32 | 2023 | Ryaltris |
| Merck Sharp & Dohme LLC | $15.25 | 2023 | |
| Intersect Ent, INC. | $14.67 | 2022 | |
| Phadia US INC. | $14.39 | 2023 | Immunocap |
| Neurent Medical Limited | $13.12 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Olympus America INC. | $12.80 | 2023 | Rhino-Laryngo Videoscope |
| Arbor Pharmaceuticals, INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avani Ingley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.